Matt Gravett MD MSPH
banner
mattgravett.bsky.social
Matt Gravett MD MSPH
@mattgravett.bsky.social
ID/HIV MD & Researcher 🩺 📈 📊 HIV/STIs. 🟢🟡🐲. 🏳️‍🌈 🐻. He/him. 🥁🎷🎺🥃🍺🌮🧀🎮. Bham,AL. Views are my own.
A decade out from VOICE & FEM PrEP, and we still see that poor oral PrEP adherence drives HIV acquisitions in Purpose 1. Excellent presentation on the F/TAF data. So, have we learned anything new? At least we maybe know how to use these TAF data, but what’s next to get TAF approved? #CROI #HIVsky
March 12, 2025 at 5:45 PM
Reposted by Matt Gravett MD MSPH
Speaking at the #CROI2025 symposium on LA #PrEP, Cissy Kityo of JCRC calls on the field to learn lessons from oral PrEP and finally speed scale up of long-acting PrEP. It's not just the product, it's the price and commitments to purchase product that will speed rollout.
March 12, 2025 at 12:02 AM
4 days on-demand PrEP optimized for protecting women #CROI #CROI2025 #HIVsky
March 11, 2025 at 6:41 PM
Promising new data for on-demand PrEP strategies for ciswomen! It’s about damn time we catch up with more options for protecting women!
#CROI #CROI2025 #HIVsky
March 11, 2025 at 6:31 PM
Rebecca Denison gave a sobering and intense call to action. They won’t stop, and neither will we. #CROI #CROI2025 #HIVsky
March 10, 2025 at 1:25 AM
I’m starting a new writing group with Carrie, Miranda, and Charlotte. Samantha is busy. Who do you write with? #IDSky
February 11, 2025 at 12:22 AM
Reposted by Matt Gravett MD MSPH
PEPFAR waiver in place. #econsky
February 1, 2025 at 9:34 PM
Long-time lurker, first-time poster.
February 1, 2025 at 3:39 PM